Large responses to antidepressants or methodological artifacts? A secondary analysis of STAR*D, a single-arm, open-label, non-industry antidepressant trial
View abstract on PubMed
Summary
This summary is machine-generated.This study attempted to replicate findings of a trimodal antidepressant response distribution but found a bimodal distribution instead. Results suggest mixture modeling is unreliable for clinical trial analysis.
Area Of Science
- Psychiatry and Clinical Psychology
- Biostatistics and Psychometrics
Background
- Previous research suggested antidepressant trial response follows a trimodal distribution, with distinct large, medium, and small effect subgroups.
- Replicating this finding is crucial for understanding antidepressant efficacy and patient heterogeneity.
Purpose Of The Study
- To replicate the trimodal distribution of antidepressant response identified by Stone et al. (2022) using finite mixture modeling.
- To assess the reliability of mixture modeling for analyzing clinical antidepressant trial data.
Main Methods
- Finite mixture modeling was applied to Hamilton Depression Rating Scale (HDRS) differences from the STAR*D study (n=2184).
- Analyses were conducted for different depression severity levels, imputed values, and patient-reported outcomes.
- Replication required a trimodal model with components comparable to Stone et al.'s findings.
Main Results
- The best fitting models were either bimodal or trimodal, but the trimodal solution did not meet replication criteria.
- A bimodal model identified two components: one with a mean HDRS change of -13.0 (65.3% of patients) and another with -1.8 (34.7%).
- The trimodal model's largest effect component differed substantially in size and effect from Stone et al.'s findings; patient-reported outcomes showed unimodal or bimodal distributions.
Conclusions
- This analysis failed to replicate the trimodal antidepressant response distribution reported by Stone et al.
- Findings suggest that mixture modeling results are not sufficiently reliable for regulatory purposes or to replace traditional methods comparing mean differences between treatment arms.
Related Concept Videos
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
The placebo effect is commonly described in terms of testing the effectiveness of a new medication. Imagine that you work in a pharmaceutical company, and you think you have a new drug that is effective in treating depression. To demonstrate that your medication is effective, you run...
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

